Events and conferences
Addressing the rate limiting step in vaccine discovery: a new paradigm in mRNA synthesis
Decades of mRNA research and advances in nanotechnology led to mRNA vaccine development and approval during the COVID-19 pandemic. However, realizing the full potential of mRNA-based therapeutics requires optimizing the discovery pipeline. In this webinar supported by Codex DNA, Krishna Kannan will discuss how innovations in synthetic biology automation improve the mRNA workflow and accelerate vaccine development.
11am Eastern // 8am Pacific
RNA Leaders USA Congress
LSX are known for bringing life science investors together to assess and meet with the most promising up and coming biotech companies. When the first mRNA vaccines hit the market in 2020, our investors asked us to look at the resurgence of therapeutics targeting or made of RNA with the view to developing a high-level industry conference. And so, RNA Leaders was born!
Synthetic Biology and Coronavirus: Preventing Future Pandemics
In this GEN webinar, our distinguished speaker, Dr. Silvi Rouskin, will focus much of her presentation on the biology of coronaviruses and how synthetic biology enables the study of coronavirus gene expression and recombination. This groundbreaking research ultimately aims to lead to a greater understanding of these processes while expediting the design of novel therapeutics and helping to prepare for future pandemics.
11am Eastern // 8am Pacific
PEGS Summit Europe
Network with more than 1,000 colleagues at PEGS Europe, the largest protein & antibody engineering event in Europe, which has been described as “the best biologics technology meeting in Europe.”
Session: November 15, 2022 10:00 – 10:30am
Booth: #415
Antibody Engineering & Therapeutics
The Antibody Society is an international, non-profit representing individuals and organizations involved in antibody-related research and development. The Society has a variety of initiatives and working groups focused on improving the antibody field.